TrueMark Investments LLC Has $1.55 Million Stake in Colgate-Palmolive Company $CL

TrueMark Investments LLC increased its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 2.0% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 17,071 shares of the company’s stock after purchasing an additional 334 shares during the quarter. TrueMark Investments LLC’s holdings in Colgate-Palmolive were worth $1,552,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Westend Capital Management LLC boosted its holdings in Colgate-Palmolive by 111.1% during the first quarter. Westend Capital Management LLC now owns 266 shares of the company’s stock worth $25,000 after purchasing an additional 140 shares during the last quarter. Cornerstone Planning Group LLC raised its position in Colgate-Palmolive by 1,913.3% during the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock worth $28,000 after acquiring an additional 287 shares in the last quarter. Saudi Central Bank bought a new stake in Colgate-Palmolive during the first quarter worth $29,000. Ransom Advisory Ltd bought a new stake in Colgate-Palmolive during the first quarter worth $33,000. Finally, Harel Insurance Investments & Financial Services Ltd. bought a new stake in Colgate-Palmolive during the first quarter worth $37,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of CL opened at $79.14 on Friday. The firm has a market capitalization of $63.96 billion, a PE ratio of 22.23, a PEG ratio of 4.64 and a beta of 0.34. The company’s 50-day moving average is $81.96 and its 200-day moving average is $87.34. Colgate-Palmolive Company has a fifty-two week low of $76.68 and a fifty-two week high of $100.54. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business had revenue of $5.11 billion for the quarter, compared to the consensus estimate of $5.03 billion. During the same period in the prior year, the company posted $0.91 earnings per share. Colgate-Palmolive’s revenue was up 1.0% compared to the same quarter last year. Equities analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be paid a $0.52 dividend. The ex-dividend date is Friday, October 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.6%. Colgate-Palmolive’s dividend payout ratio is 58.43%.

Wall Street Analysts Forecast Growth

CL has been the topic of several analyst reports. Bank of America dropped their price target on shares of Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Piper Sandler initiated coverage on shares of Colgate-Palmolive in a research report on Friday, October 3rd. They set a “neutral” rating and a $84.00 price target on the stock. Deutsche Bank Aktiengesellschaft set a $86.00 price target on shares of Colgate-Palmolive in a research report on Friday, October 10th. UBS Group dropped their price objective on shares of Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Finally, Barclays dropped their price objective on shares of Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. Eight analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $92.21.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.